Medicare Enrolled
Dr. Opada Alzohaili, MD
Internal Medicine · Dearborn, MI
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Alzohaili from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Alzohaili?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Alzohaili
Dr. Opada Alzohaili is an internal medicine specialist in Dearborn, MI, with 20 years of NPI registration. Based on federal Medicare data, Dr. Alzohaili performed 13,261 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Alzohaili received a total of $25,261 from 76 pharmaceutical and/or device companies across 607 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Alzohaili is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 1% volume in MI
$25,261 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗13,261
Medicare services
Top 1% in MI for internal medicine
Not available
Unique patients (not deduplicated)
$22
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Testosterone injection An injection of testosterone cypionate, a form of testosterone hormone. The dose is measured in milligrams. |
7,900 | $0 | $0 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
1,466 | $48 | $70 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,080 | $97 | $140 |
| Blood glucose level test A test that measures the amount of sugar in your blood. |
513 | $4 | $10 |
| Chronic care management, additional 20 min/month This service covers an extra 20 minutes of clinical staff time directed by a healthcare professional for managing two or more chronic conditions each calendar month. |
431 | $37 | $70 |
| Continuous glucose monitoring with interpretation This procedure involves monitoring blood sugar levels in tissue fluid using a sensor placed under the skin, along with the interpretation and reporting of the results. |
282 | $27 | $80 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
174 | $11 | $30 |
| Ultrasound of head and neck soft tissue This procedure uses sound waves to create images of the soft tissues in the head and neck area. It allows for the visualization of structures beneath the skin without using radiation. |
173 | $87 | $200 |
| Remote patient monitoring management, 20 min/month Management based on results from remote vital sign monitoring for the first 20 minutes per calendar month. |
166 | $38 | $100 |
| Remote vital sign monitoring management, each additional 20 minutes This code covers the time spent by a provider managing patient data from remote vital sign monitoring devices. It applies to each additional 20-minute increment beyond the initial monthly service period. |
148 | $32 | $100 |
| Hemoglobin A1c test (diabetes monitoring) A blood test that measures your average blood sugar levels over the past two to three months. |
135 | $9 | $35 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
109 | $70 | $105 |
| Continuous glucose monitoring, sensor under skin This procedure involves continuous monitoring of blood sugar levels in tissue fluid using a sensor placed under the skin with provider-supplied equipment. |
101 | $111 | $300 |
| Ultrasound of arm and leg arteries A non-invasive imaging test that uses sound waves to examine the blood vessels in the arms and legs. It evaluates blood flow and checks for blockages or other vascular issues. |
95 | $83 | $300 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
78 | $131 | $208 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
77 | $1 | $20 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
59 | $140 | $225 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
55 | $62 | $100 |
| Ultrasound-guided fine needle aspiration biopsy, first lesion A biopsy procedure where a thin needle is used to collect tissue samples from a growth, guided by ultrasound imaging. This code applies to the first lesion or mass sampled during the session. |
33 | $111 | $200 |
| Bone density scan (DEXA) A test that uses low-dose X-rays to measure bone mineral density in the hip, pelvis, and spine. It helps assess bone strength and risk of fractures. |
33 | $37 | $200 |
| Extended office visit by clinical staff, first hour An extended office or outpatient visit provided by clinical staff lasting at least one hour. |
32 | $15 | $59 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
29 | $26 | $125 |
| Telephone medical discussion, 21-30 minutes A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone. |
25 | $89 | $125 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
23 | $51 | $143 |
| Continuous glucose monitoring, tissue fluid This procedure involves continuous monitoring of blood sugar levels in tissue fluid using a sensor placed under the skin. |
15 | $49 | $75 |
| Intravenous drug injection A procedure involving the administration of a medication or substance directly into a vein. |
15 | $30 | $100 |
| Normal saline infusion, 250 cc Administration of 250 cubic centimeters of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater fluid. |
14 | $1 | $5 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
0.5% high complexity
63.8% medium
35.7% routine
Industry Payment Transparency
Open Payments through 2024 ↗$25,261
Total received (2018-2024)
Avg $3,609/year across 7 years
Top 4% in MI for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
76
Companies
607
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,663
2023
$1,667
2022
$2,001
2021
$4,369
2020
$1,281
2019
$10,167
2018
$2,112
Payments by company (2024)
Medtronic, Inc.
$1,573
Amgen Inc.
$589
Novo Nordisk Inc
$527
CeQur Corporation
$192
Lilly USA, LLC
$144
Otsuka America Pharmaceutical, Inc.
$123
Abbott Laboratories
$100
Corcept Therapeutics
$70
Tolmar, Inc.
$53
Neurocrine Biosciences, Inc.
$43
Nevro Corp.
$42
Ultragenyx Pharmaceutical Inc.
$39
Amneal Pharmaceuticals LLC
$32
Ascendis Pharma Inc
$29
Insulet Corporation
$22
RECORDATI_RARE_DISEASES_INC.
$18
PFIZER INC.
$18
Averitas Pharma Inc.
$17
Verity Pharmaceuticals Inc.
$16
Chiesi USA, Inc.
$15
Top 3 companies account for 73.4% of 2024 payments
All-time payments by company (2018-2024) ›
Insulet Corporation
$6,122
Medtronic, Inc.
$3,602
Novo Nordisk Inc
$2,443
Medtronic MiniMed, Inc.
$1,449
Amgen Inc.
$1,193
Senseonics, Incorporated
$866
Lilly USA, LLC
$796
AstraZeneca Pharmaceuticals LP
$584
Abbott Laboratories
$497
Becton, Dickinson and Company
$470
CeQur Corporation
$388
Corcept Therapeutics
$339
Antares Pharma, Inc.
$303
Ascendis Pharma, Inc.
$300
Bayer HealthCare Pharmaceuticals Inc.
$283
Regeneron Healthcare Solutions, Inc.
$282
Horizon Therapeutics plc
$281
Radius Health, Inc.
$275
Janssen Pharmaceuticals, Inc
$263
MannKind Corporation
$253
Amarin Pharma Inc.
$239
Pharmacosmos Therapeutics Inc.
$231
Daiichi Sankyo Inc.
$230
Mannkind Corporation
$229
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$202
Merck Sharp & Dohme Corporation
$175
SANOFI-AVENTIS U.S. LLC
$162
Strongbridge US INC.
$143
PFIZER INC.
$128
Bayer Healthcare Pharmaceuticals Inc.
$125
Otsuka America Pharmaceutical, Inc.
$123
RECORDATI_RARE_DISEASES_INC.
$123
Xeris Pharmaceuticals, Inc.
$115
Ascensia Diabetes Care Us Inc.
$113
Ultragenyx Pharmaceutical Inc.
$111
Nevro Corp.
$108
Acella Pharmaceuticals, LLC
$102
Endo Pharmaceuticals Inc.
$96
Valeritas, Inc.
$85
Rhythm Pharmaceuticals, Inc.
$81
Cardiovascular Systems Inc.
$80
Amneal Pharmaceuticals LLC
$76
Ascendis Pharma Inc
$75
Orexigen Therapeutics, Inc.
$68
Alexion Pharmaceuticals, Inc.
$63
Novartis Pharmaceuticals Corporation
$56
Boehringer Ingelheim Pharmaceuticals, Inc.
$55
Tolmar, Inc.
$53
Zealand Pharma US, Inc.
$53
Currax Pharmaceuticals LLC
$49
Clarus Therapeutics Inc.
$48
Shire North American Group Inc
$48
Acerus Pharmaceuticals Corporation
$43
Neurocrine Biosciences, Inc.
$43
Eisai Inc.
$42
Ipsen Biopharmaceuticals, Inc
$40
DEXCOM, INC.
$39
Dexcom, Inc.
$39
Nalpropion Pharmaceuticals, Inc.
$38
Averitas Pharma Inc.
$35
EISAI INC.
$32
AbbVie, Inc.
$29
Ferring Pharmaceuticals Inc.
$26
IBSA Pharma Inc.
$26
Supernus Pharmaceuticals, Inc.
$21
Astellas Pharma US Inc
$20
Merck Sharp & Dohme LLC
$19
Lexicon Pharmaceuticals, Inc.
$19
Verity Pharmaceuticals Inc.
$16
Gilead Sciences, Inc.
$16
Mission Pharmacal Company
$15
Chiesi USA, Inc.
$15
Esperion Therapeutics, Inc.
$14
GRT US Holding, Inc.
$13
Nalpropion Pharmaceuticals LLC
$13
VIVUS, Inc.
$12
Top 3 companies account for 48.2% of all-time payments
Associated products mentioned in payments ›
AFREZZA · Androgel · BD NANO · BD Nano · BD Nano 2nd Gen Pen Needle · BRILINTA · Belviq · Binosto · CONTRAVE · CRENESSITY · CYCLOSET · CeQur Simplicity · Crysvita · DEXCOM G6 TRANSMITTER · Dexcom G6 Transmitter · ELIGARD · ENTRESTO · EVENITY · EVERSENSE E3 SMART TRANSMITTER KIT · Eversense · FARXIGA · FENSOLVI · FREESTYLE LIBRE · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FREESTYLE LIBRE PRO · FreeStyle Libre 2 · FreeStyle Libre blood glucose Flash Monitoring System · GENOTROPIN · GVOKE PFS · Guardian Connect · HUMALOG · HUMULIN · HUMULIN R 500 · HUMULIN U · INJECTAFER · INPEN SMART INSULIN DELIVERY SYSTEM · INVOKANA · InPen · Inpefa · JANUVIA · JARDIANCE · JATENZO · KEVEYIS · Kerendia · Korlym · LEQVIO · LIBTAYO · MACRILEN · MINIMED 770G · MINIMED 780G · MOUNJARO · MYCAPSSA · Macrilen · Minimed 670G System · Monoferric · NASCOBAL · NATPARA · NATPARA (PARATHYROID HORMONE) · NEXLIZET · NOCDURNA · NP Thyroid · NP Thyroid 60 · Natesto · Norditropin · NovoLog · OTREXUP · Omnia · Omnipod · Ozempic · PRALUENT · PRALUENT ALIROCUMAB INJECTION · Peripheral Orbital Atherectomy System · Prolia · QSYMIA · QUTENZA · Qutenza · RECORLEV · REXULTI · RYBELSUS · Repatha · Rybelsus · SIGNIFOR LAR · SKYTROFA · SOLIQUA · SOLIQUA 100/33 · SOMATULINE DEPOT · SOMAVERT · STEGLATRO · STRENSIQ · SUPPRELIN · Saxenda · Senza · Skytrofa · Sogroya · Somatuline Depot · Strensiq · TEPEZZA · TLANDO · TOUJEO · TRULICITY · Tirosint · Tlando · Tresiba · Tymlos · UNITHROID · V-GO · Vascepa · Veozah · Victoza · Wegovy · XARELTO · XYOSTED · ZEGALOGUE · ZEPBOUND · ZOMACTON
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Internal medicine physicians in nearby ZIP areas
3,178
County median income
$59,521
Nearest hospital to ZIP centroid (approximate)
BEAUMONT HOSPITAL - DEARBORN
3.8 mi
3.8 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Alzohaili is a clinical cardiology specialist, with above-average Medicare volume (top 1% in MI), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Alzohaili experienced with testosterone injection?
Based on Medicare claims data, Dr. Alzohaili performed 7,900 testosterone injection services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Alzohaili receive payments from pharmaceutical companies?
Yes. Dr. Alzohaili received a total of $25,261 from 76 companies across 607 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Alzohaili's costs compare to other internal medicine physicians in Dearborn?
Dr. Alzohaili's average Medicare payment per service is $22. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Alzohaili) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Internal Medicine Physicians in Dearborn
Browse internal medicine physicians in Dearborn ranked by procedure volume and transparency data.
Highest volume
Top Internal Medicine Physicians in MI
Internal medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Internal Medicine Physicians in MI
Which MI internal medicine physicians receive the most from drug and device companies.
By company
Insulet Corporation Payments to Doctors
See all physicians who received payments from Insulet Corporation.
By company
Medtronic, Inc. Payments to Doctors
See all physicians who received payments from Medtronic, Inc.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology